Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis--a review.

J C Alden1

  • 1Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.

Clinical Therapeutics
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Menopausal osteoporosis is a significant health issue, but hormone replacement therapy (HRT), vitamin D, and calcium supplements can prevent bone loss and fractures. Early identification of "fast bone losers" allows for tailored treatment to reduce fracture risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A teaching program in primary care.

Pennsylvania medicine·1975
Same author

Comparative dynamics of salmonella infection after primary and secondary challenge of mice exposed to 10 and 23 C.

Infection and immunity·1973
Same author

Symbiosis in planning and operation of a comprehensive health center and community mental health program in Philadelphia.

American journal of public health·1972
Same author

Invasiveness of salmonella administered orally to cold-exposed mice.

Infection and immunity·1970
Same journal

Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

Clinical therapeutics·2026
Same journal

Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

Clinical therapeutics·2026
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
See all related articles

Area of Science:

  • Endocrinology
  • Geriatrics
  • Bone Metabolism

Background:

  • Osteoporosis is a prevalent medical problem, particularly in postmenopausal women.
  • Key causes include ovarian failure and reduced adrenal androgen production, leading to menopausal osteoporosis.
  • Trabecular bone loss and vertebral fractures are significant concerns in this demographic.

Purpose of the Study:

  • To investigate the feasibility of preventing trabecular bone loss and vertebral fractures in menopausal patients.
  • To identify at-risk individuals ('fast bone losers') using clinical and laboratory methods.
  • To evaluate the efficacy of hormone replacement therapy (HRT) and nutritional supplements in managing osteoporosis.

Main Methods:

  • Identification of at-risk women through office-based and laboratory techniques.

Related Experiment Videos

  • Administration of estrogen therapy to reduce osteoclastic resorption and preserve bone mass.
  • Use of progesterone and anabolic hormones to stimulate osteoblastic bone formation.
  • Monitoring treatment effectiveness via 24-hour hydroxyproline and calcium excretion, and serum FSH levels.
  • Consideration of androgen replacement (e.g., nandrolone decanoate) for fracture victims.
  • Supplementation with vitamin D, calcium, and potentially fluoride.

    • Main Results:

    • Estrogen therapy effectively reduces osteoclastic resorption and preserves bone mass.
    • Combination therapy with estrogen and progesterone mitigates uterine malignancy risk.
    • Monitored hormone, vitamin D, and calcium supplementation reduced fracture frequency by 40-60% over three years.
    • Fluoride supplements, alongside other treatments, appear to decrease vertebral fracture rates.

    Conclusions:

    • Menopausal osteoporosis is a serious, potentially fatal condition that can be managed effectively.
    • Hormone replacement therapy, combined with vitamin D, calcium, and potentially androgens and fluoride, significantly reduces fracture risk.
    • Tailored treatment strategies can dramatically alter the suffering, disability, and mortality associated with osteoporosis-induced fractures.